 | Up a level |
Hopkins-Donaldson, Sally; Belyanskaya, Larisa L; Simões-Wüst, Ana Paula; Sigrist, Brigitte; Kurtz, Stefanie; Zangemeister-Wittke, Uwe; Stahel, Rolf (2006). p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma. Neoplasia, 8(7), pp. 551-9. New York, N.Y.: Nature America 10.1593/neo.06148
Grzelinski, Marius; Steinberg, Florian; Martens, Tobias; Czubayko, Frank; Lamszus, Katrin; Aigner, Achim (2009). Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia, 11(2), pp. 145-56. New York, N.Y.: Nature America 10.1593/neo.81040
Tièche, Colin; Gao, Yanyun; Bührer, Elias; Hobi, Nina; Berezowska, Sabina Anna; Wyler, Kurt; Froment, Laurène; Weis, Stefan; Peng, Ren-Wang; Bruggmann, Rémy; Schär, Primo; Amrein, Michael Alex; Hall, Sean; Dorn, Patrick; Kocher, Gregor; Riether, Carsten; Ochsenbein, Adrian; Schmid, Ralph; Marti, Thomas (2019). Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549. Neoplasia, 21(2), pp. 185-196. Elsevier 10.1016/j.neo.2018.09.008
Lee, Rachel S; Zhang, Luxi; Berger, Adeline; Lawrence, Mitchell G; Song, Jiangning; Niranjan, Birunthi; Davies, Rebecca G; Lister, Natalie L; Sandhu, Shahneen K; Rubin, Mark A.; Risbridger, Gail P; Taylor, Renea A; Rickman, David S; Horvath, Lisa G; Daly, Roger J (2019). Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target. Neoplasia, 21(4), pp. 389-400. Elsevier 10.1016/j.neo.2019.02.005
Freiberger, Sandra N; Brada, Muriel; Fritz, Christine; Höller, Sylvia; Vogetseder, Alexander; Horcic, Milo; Bihl, Michel; Michal, Michal; Lanzer, Martin; Wartenberg, Martin; Borner, Urs; Bode, Peter K; Broglie, Martina A; Rordorf, Tamara; Morand, Grégoire B; Rupp, Niels J (2021). SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia, 23(5), pp. 473-487. Elsevier 10.1016/j.neo.2021.03.008
Patke, Rodhan; Harris, Anna E; Woodcock, Corinne L; Thompson, Rachel; Santos, Rute; Kumari, Amber; Allegrucci, Cinzia; Archer, Nathan; Gudas, Lorraine J; Robinson, Brian D; Persson, Jenny L; Fray, Rupert; Jeyapalan, Jennie; Rutland, Catrin S; Rakha, Emad; Madhusudan, Srinivasan; Emes, Richard D; Muyangwa-Semenova, Musalwa; Alsaleem, Mansour; De Brot, Simone; ... (2024). Epitranscriptomic mechanisms of androgen signalling and prostate cancer. Neoplasia, 56, p. 101032. Elsevier 10.1016/j.neo.2024.101032
Sconocchia, Giuseppe; Eppenberger-Castori, Serenella; Zlobec, Inti; Karamitopoulou, Evanthia; Arriga, Roberto; Coppola, Andrea; Caratelli, Sara; Spagnoli, Giulio Cesare; Lauro, Davide; Lugli, Alessandro; Han, Junyi; Iezzi, Giandomenica; Ferrone, Cristina; Ferlosio, Amedeo; Tornillo, Luigi; Droeser, Raoul; Rossi, Piero; Attanasio, Antonio; Ferrone, Soldano and Terracciano, Luigi (2014). HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker. Neoplasia, 16(1), pp. 31-42. Nature America 10.1593/neo.131568
